DOCSLIB.ORG

Uncovering New Strategies to Reduce TB Susceptibility in HIV- Infected Individuals

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Uncovering New Strategies to Reduce TB Susceptibility in HIV- Infected Individuals Infectious Diseases Uncovering new strategies to reduce TB susceptibility in HIV- infected individuals Dr Henry Mwandumba is a Clinician Scientist at the Malawi-Liverpool- material to acidic, pathogen-degrading Wellcome Trust Clinical Research Programme, and Consultant Physician lysosomes inside the cell. at Queen Elizabeth Central Hospital, Blantyre, Malawi in Southeast The endosomal-lysosomal system is an Africa. He leads a group of researchers with two main goals; to extremely effective barrier against bacterial understand how humans develop immunity to TB in the lungs, and why infection, comprising three major activities: the risk of TB is greater during HIV infection. phagocytosis, endocytosis, and endosomal acidification. During phagocytosis, AM engulf bacteria, which then become enclosed into intracellular organelles called phagosomes. uberculosis (TB), caused by While ART has significantly reduced During endocytosis, phagosomes are the bacterium Mycobacterium the rates of HIV and HIV-associated TB trafficked through the AM in compartments tuberculosis, is a serious worldwide, TB is still 5-10 times more called endosomes, eventually fusing with cause of disease and mortality prevalent in HIV-infected adults on ART lysosomes, which are specialised organelles worldwide, especially in than in HIV-uninfected individuals. The risk containing degradative enzymes. Lysosomal developing countries. Co-infection with of developing active TB is increased in HIV- enzymes function under acidic conditions, Tthe human immunodeficiency virus (HIV) infected individuals, even before significant and progressive endosomal acidification is aggravates this situation, and puts intense CD4+ T cell depletion occurs. These facts therefore a prerequisite for a fully functioning pressure on national healthcare services in indicate that CD4+ T cells are not the only endosomal-lysosomal system. sub-Saharan Africa, where up to 80% of TB determinant of TB risk, and that increasing patients are HIV-infected, and where TB is their numbers alone is not enough to ANSWERS FROM HUMAN LUNGS now the leading cause of death in HIV- maintain full protection against TB. As part of a long-standing research infected individuals. programme at Queen Elizabeth Central The increased risk of TB in HIV sufferers Hospital, Dr Mwandumba’s group has access Dr Mwandumba believes that a better also suggests that HIV infection alters the to lung samples from HIV-infected, TB- understanding of the mechanisms immune environment in the lung, since TB infected, co-infected, and healthy human underlying resistance and susceptibility most often infects the lung. The important volunteers. The group employs a combination to TB is essential to reduce the incidence question of how HIV impacts lung immunity of microscopy, flow cytometry (cell staining of HIV-associated TB, and to develop new and susceptibility to TB has dominated Dr and counting), and molecular biology therapies for TB in general. Mwandumba’s research for over a decade. techniques to visualise immune cells in these lung specimens, to assess their function, and ANTIRETROVIRAL THERAPY IS ALVEOLAR MACROPHAGES – THE to detect infection-induced changes in their NOT ENOUGH BIG EATERS behaviour. Antiretroviral therapy (ART) is the standard Alveolar macrophages (AM) are highly treatment for HIV, and it usually involves a differentiated immune cells that occupy the TB INFECTION ARRESTS combination of drugs that work together interface of the external environment and the AM PHAGOSOMES to slow down viral replication. CD4+ T cells alveolar tissue of the lungs. They are often the It is well documented that HIV and TB can are a subset of white blood cells that are first professional phagocytes encountered synergise and provoke immune responses that targeted by HIV. Successful ART therapy during TB infection, and like all phagocytes, exacerbate both infections. However, despite leads to an increase in this cell population, they are capable of phagocytosing (eating), the importance of AM in lung immunity, thus boosting the body’s immune defences. internalising and delivering pathogen-derived very few researchers have investigated their physiology in TB patients. Dr Mwandumba’s research addressed this deficit in a study examining the properties of human AM My vision is to see a substantial obtained from the lungs of patients infected reduction in this high burden of HIV- with TB. The study revealed that the ability of AM associated TB by undertaking relevant to phagocytose synthetic beads was not clinical research affected by HIV or TB infection. Furthermore, www.researchfeatures.com 27 Infectious Diseases Detail RESEARCH OBJECTIVES Dr Henry Mwandumba’s aim with What has been the biggest technical to reverse the direct (killing of HIV-infected his research is to gain a greater challenge with your research to date? CD4+ T cells) and indirect (activation and understanding of how humans develop We conduct internationally competitive accelerated death of immune cells) effects immunity to TB in the lung and why the cutting-edge biomedical research in of HIV in various parts of the body in risk of TB is increased with HIV. an area with a high disease burden but order to create an environment that allows limited resources for research. We are repopulation of the lung with new TB- FUNDING able to do so because we have invested a specific and non-specific immune cells. • The Wellcome Trust significant amount of time and resources • Bill and Melinda Gates Foundation into establishing appropriate infrastructure, Is it worthwhile vaccinating against TB • National Institutes of Health developing unique and novel assays to in areas with high incidence rates of HIV • Medical Research Council (UK) enhance our work, as well as developing and infection? retaining highly skilled and competent young BCG vaccine, the only TB vaccine currently COLLABORATORS researchers. Reaching and maintaining all available, is not recommended for use in HIV- Key partners these goals have been the biggest technical infected individuals. The vaccine contains • University of Malawi College of challenges of my research career so far. an attenuated (reduced virulence) strain of Medicine, Malawi bovine TB, which can cause disseminated • Liverpool School of Tropical Medicine, Does TB also coincide with other TB in individuals with weakened immune UK infections, as it does with HIV? systems, including those infected with HIV. • Queen Elizabeth Central Hospital, Co-infection with TB and infections other It is therefore not worthwhile giving this Malawi than HIV has been reported in some HIV- vaccine to HIV-infected individuals in areas • Cornell University, USA infected and HIV-uninfected individuals with high incidence of HIV infection. • University of Massachusetts, USA but there is lack of a direct link or synergy the endosomal/lysosomal activities of AM IMPACT OF HIV ON ALVEOLAR The group developed novel assays to between these infections as we see with HIV How effective is antibiotic treatment Collaborators were equally intact in cells derived from MACROPHAGES detect HIV-infected AM by combining and TB. against TB in HIV-infected individuals? • Dr Kondwani Jambo, Malawi-Liverpool- HIV- or TB-infected individuals, when The role of AM in immunity against flow cytometry with a technique known as Antibiotics currently available for TB are Wellcome Trust Clinical Research using synthetic markers for endocytosis respiratory pathogens is undisputable. fluorescence in situ hybridisation (FISH). Your research revealed that it takes at effective for the treatment of TB both Programme and phagosomal acidification. However, It is also well accepted that HIV infection In simple terms, they used detectable least four years on ART before HIV- in HIV-uninfected and HIV-infected • Prof David Russell, Cornell University Mycobacterium tuberculosis-containing increases susceptibility to lower respiratory fluorescent probes to bind HIV-specific infected individuals achieve similar individuals provided they are taken for the • Prof Bertie Squire, Liverpool School of phagosomes in TB-infected AM failed tract infections such as TB. What is less clear messenger RNA, allowing the group to detect TB-specific immune responses to HIV- recommended period of time, treatment Tropical Medicine to acidify and fuse with lysosomes, however, is the exact consequence of HIV and track HIV in different cell populations. uninfected individuals. Why do you think doses are not missed, and the TB is not • Prof Paul Clapham, University of thus halting the progression of the infection on the physiological functions of AM. They also measured AM phagocytic capacity this takes such a long time? resistant to the antibiotics used. Massachusetts endosomal-lysosomal system, in and proteolysis (enzymatic degradation of This likely reflects the time it takes for ART agreement with earlier cell culture- Within the past decade, evidence has proteins) using reporter beads. BIO based studies. emerged for two distinct AM populations, Henry is Clinician Scientist at the Malawi- small and large. This discovery prompted Dr They found that HIV imparts differential Liverpool-Wellcome Trust Clinical Dr Mwandumba and his colleagues Mwandumba’s group to examine the impact effects on key AM functions. Small AM were Research Programme and Consultant were the first to demonstrate that of HIV infection on AM function in a highly more likely to be infected by HIV, resulting on ART. Dr Mwandumba’s group set out to and may explain why the risk
Load more

Recommended publications
  • CORRECTED Aston Phd Thesis
    Community-acquired pneumonia in Malawian adults: Aetiology and predictors of mortality. Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor of Philosophy Stephen James Aston MBChB, BMedSc, MRCP, DTMH August 2016 Declaration I declare that this thesis was composed by me and that the work contained therein is my own, except where explicitly stated otherwise in the text. Any contribution of others is described briefly below and in detail at the beginning of relevant chapters. The work within this thesis has not been submitted in whole or in part for any other degree or professional qualification. My supervisors Professor Stephen Gordon (Malawi Liverpool Wellcome Trust Clinical Research Programme (MLW), Malawi) Professor Robert Heyderman (University College London, UK) and Dr Henry Mwandumba (MLW) provided advice on all aspects of the design, conduct and analysis of the research presented here. Professor Paul Garner (Liverpool School of Tropical Medicine, UK) advised on the methodology and analysis of the systematic review presented in chapter 2. Professor Charles Feldman (University of Witwatersrand, South Africa) independently reviewed all titles and corroborated study selection. Victoria Lutje (search strategist) advised on the search strategy and performed the database searches. The Malawian adult lower respiratory tract infection severity, aetiology and outcome (MARISO) study presented in chapters 3, 4 and 5 was one of several concurrently recruiting adult respiratory infection projects based at MLW and Queen Elizabeth Central Hospital (QECH), Malawi. Recruitment to the MARISO study was nested within that of the Burden and Severity of HIV-associated Influenza (BASH-FLU) Study (Principal Investigator: Dr Antonia Ho) and integrated with that of the existing severe acute respiratory infection surveillance programme (Principal Investigators: Dr Dean Everett and Dr Ingrid Peterson).
    [Show full text]
  • Page 1 of 13 JOB DESCRIPTION POST Senior Clinical Lecturer in Infectious Diseases CONTRACT Permanent REFERENCE NO 510-18 REPORTS
    JOB DESCRIPTION POST Senior Clinical Lecturer in Infectious Diseases CONTRACT Permanent REFERENCE NO 510-18 REPORTS TO Head of Department of Clinical Sciences or International Public Health ROLE PURPOSE/SUMMARY The Senior Clinical Lecturer will collaborate with colleagues and existing portfolios of relevant research at LSTM to develop an applied health research programme (to include operational, implementation and health systems research) focused on lung health and tuberculosis in low- and middle-income countries at the Liverpool School of Tropical Medicine (LSTM). The post holder will combine clinical insights on TB care-seeking and treatment with other research disciplinary perspectives in order to bring innovation to LSTM’s growing portfolio of applied health research. The post will include responsibility for development and expansion of the tropical out-patient clinic at LSTM. SCOPE/BACKGROUND This is a strategically important post in expanding LSTM’s activities in health systems research and TB. The post is jointly funded by the NHS and will underpin and potentially ultimately lead the clinical activities of LSTM. In patient-clinical service provision will occur at the Tropical and Infectious Diseases Unit through an Honorary Consultant contract at the Royal Liverpool and Broadgreen University Hospitals NHS Trust; outpatient activity will be undertaken predominantly in the LSTM referral clinic. ROLE SPECIFIC RESPONSIBILITIES KEY KEY ACTIONS RESPONSIBILITIES These set out how the Key Responsibilities will be achieved 1 Research To
    [Show full text]
  • ACF Infectious Diseases Programme Details in Conjunction with the University of Liverpool Recruitment to Posts Starting in August 2019
    ACF Infectious Diseases Programme Details in conjunction with the University of Liverpool Recruitment to posts starting in August 2019 Post availability There is up to 1 post in Infectious Diseases with a research theme of Medical Education You can apply at ST3 level in this round of recruitment. 2019 entry is at ST3 level. This will then include further years at ST4 and ST5 Overview You can find generic information about Academic Clinical Fellowships in the North West plus links to the National Institute for Health Research’s guidance via https://www.nwpgmd.nhs.uk/nihr-academic-clinical-fellowships-glance Entry to the training post will be at ST3 level. During the 3 year post, the trainee will be expected to complete the Combined Infection Certificate Examination and FRCpath part 2 if dual accrediting with medical microbiology or medical virology ie complete Membership of Royal college of Physicians +/- College of pathologists (specialist) exams and to prepare an application for an academic training fellowship. Hospitals in which training will take place Rotation through NHS Trusts in Merseyside, including the Royal Liverpool and Broadgreen University Hospitals NHS Trust, and other NHS teaching Trusts in Merseyside Research Institutes in which training will take place Institutes of Infection and Global Health and Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool. School of Medicine, Institute of Clinical Sciences, Faculty of Health and Life Sciences, University of Liverpool Academic Training The research project attached to this post is entitled ‘The Impact of Student Schwartz Rounds on the Multidisciplinary Team of the Future: working towards supported staff and better patient care’.
    [Show full text]
  • Evaluating the Reactivation of Herpesviruses and Inflammation As Cardiovascular and Cerebrovascular Risk Factors in Antiretrovir
    Open access Protocol BMJ Open: first published as 10.1136/bmjopen-2018-025576 on 12 September 2019. Downloaded from Evaluating the reactivation of herpesviruses and inflammation as cardiovascular and cerebrovascular risk factors in antiretroviral therapy initiators in an African HIV- infected population (RHICCA): a protocol for a longitudinal cohort study Ingrid Peterson,1,2 Ntobeko Ntusi,3 Kondwani Jambo,1,2 Christine Kelly,2,4 Jacqueline Huwa,2 Louise Afran,2 Joseph Kamtchum Tatuene ,2,5 Sarah Pett,6,7 Marc Yves Romain Henrion,1,2 Joep Van Oosterhout,8,9 Robert S Heyderman,2,10 Henry Mwandumba,1,2 Laura A Benjamin ,11,12 On behalf of the Investigators of the RHICCA study To cite: Peterson I, Ntusi N, ABSTRACT Strengths and limitations of this study Jambo K, et al. Evaluating the Introduction In Sub- Saharan Africa, the rising rates of reactivation of herpesviruses cerebrovascular and cardiovascular diseases (CBD/CVD) and inflammation as ► This is one of the first large- scale studies in Sub- are intersecting with an ageing HIV- infected population. cardiovascular and Saharan Africa to explore the relationship between cerebrovascular risk factors The widespread use of antiretroviral therapy (ART) may HIV infection, latent herpesviruses, inflammation, in antiretroviral therapy confer an additive risk and may not completely suppress and cardiovascular and cerebrovascular diseases, initiators in an African HIV- the risk associated with HIV infection. High- quality immediately after starting antiretroviral therapy infected population (RHICCA): prospective studies are needed to determine if HIV- (ART). a protocol for a longitudinal infected patients in Africa are at increased risk of CBD/ http://bmjopen.bmj.com/ ► Clinical events and death will be comprehensively cohort study.
    [Show full text]
  • Conference Program
    ConferenceAll times below are in Southern African Program time (Malawi and CET) Sunday 1st August 3:00pm – 3:15pm Welcome address: Henry Mwandumba Covid Symposium. Chair: Kondwani Jambo 3:15pm – 3:40pm Ifedayo Adetifa, KEMRI-Wellcome, Kenya, SARS-CoV-2 seroprevalence in Africa 3:40pm – 4:05pm Jason Kindrachuk, University of Manitoba, Canada, Immunopathogenesis of COVID-19 4:05pm – 4:30pm Paul Moss, University of Birmingham, UK, Cellular immunity against SARS-CoV-2 4:30pm – 4:55pm Penny Moore, NICD RSA, Natural and vaccine-induced immunity against emerging variants 4:55pm – 6:20pm Marielle Karine Bouyou-Akotet, Université des Sciences de la Santé, Gabon 6:20pm – 7:00pm Round Table Discussion: Dr. Kondwani Jambo (moderator) Is there an immune basis for the lower burden of severe COVID-19 in Africa versus elsewhere? • Clive Gray, RSA • Paul Moss • Henry Mwandumba, Malawi • Marielle Karine Bouyou-Akotet • Jason Kindrachuk • Penny Moore Monday 2nd August 10:00am – 10:05am Introduction and Chair – Clive Gray 10:05am – 10:45am Keynote address – Siamon Gordon, Mononuclear Phagocytes in health and COVID-19 infection New Frontiers in Immunology. Chair: Lucy Ochola 10:45am – 11:15am Plenary 1: Miriam Merad, Pathogenic inflammation induced by COVID 19 11:15am – 11:45am Plenary 2: Federica Sallusto, Clonal analysis of the T and B cell responses to SARS-CoV-2 (12:00pm – 1:15pm) Parallel Sessions 11:45am – 1:15pm Track 1 – Session 1: HIV Pathogenesis. Chair: Eunice Track 2 – Session 1: Cancer Epidemiology & Nduati Immunotherapy. Chair: Salem Chouaib
    [Show full text]
  • Variations in Human Monocyte-Derived Macrophage Antimicrobial Activities and Their Associations with Tuberculosis Clinical Manifestations
    medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20194043; this version posted September 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Variations in human monocyte-derived macrophage antimicrobial activities and their associations with tuberculosis clinical manifestations 1 Trinh T. B. Tram1, Vu T. N. Ha1, Do D. A. Thu1, Tran D. Dinh1, Hoang N. Nhung1, Nguyen T. 2 Hanh1, Nguyen H. Phu1, Guy E. Thwaites1,2, Nguyen T. T. Thuong1,2* 3 1Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam 4 2Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of 5 Oxford, Oxford, United Kingdom 6 * Correspondence: 7 Nguyen T. T. Thuong 8 [email protected] 9 Keywords: tuberculosis, acidification, proteolysis, human macrophage, variation 10 Abstract 11 Macrophages play a significant role in preventing infection through antimicrobial activities, 12 particularly acidification and proteolysis. Mycobacterium tuberculosis infection can lead to diverse 13 outcomes, from latent asymptomatic infection to active disease involving multiple organs. Monocyte- 14 derived macrophage is one of the main cell types accumulating in lungs following Mtb infection. The 15 variation of intracellular activities of monocyte-derived macrophages in humans and the influence of 16 these activities on the tuberculosis (TB) spectrum are not well understood. By exploiting ligand- 17 specific bead-based assays, we investigated macrophage antimicrobial activities real-time in healthy 18 volunteers (n=53) with 35 cases of latent TB (LTB), and those with active TB (ATB) and either 19 pulmonary TB (PTB, n=70) or TB meningitis (TBM, n=77).
    [Show full text]
  • Lstm Annual Report 2018/19 2018 2019 Lstm Annual Report
    LSTM ANNUAL REPORT 2018/19 2018 2019 LSTM ANNUAL REPORT 1 LSTM ANNUAL REPORT 2018/19 LSTM ANNUAL REPORT 2018/19 Vision To save lives in resource poor countries through Contents research, education and capacity strengthening Mission 03 Vision Mission Values 57 Research Management 04 Chairman’s Foreword Services To reduce the burden of sickness and mortality in disease endemic countries through the delivery of 05 Director’s Foreword 58 Research Governance and Ethics effective interventions which improve human health 06 Treasurer’s Report and are relevant to the poorest communities 59 Research Support: 07 Introduction to the Feature Developing a Translational Articles Research Pathway 08 FEATURE: Neglected 60 Education Values Tropical Diseases 62 Students and Courses 12 Department of Tropical • Making a difference to health and wellbeing 63 Clinical Diagnostic Disease Biology • Excellence in innovation, leadership and science Parasitology 15 FEATURE: Malaria and Laboratory • Achieving and delivering through partnership Other Vector Borne Diseases 64 Well Travelled Clinics • An ethical ethos founded on respect, 18 Department of Vector accountability and honesty 65 LITE Biology • Creating a great place to work and study 20 FEATURE: Resistance 66 IVCC Research and Management 67 FEPOW 24 Department of Clinical 68 LSTM in the Media Sciences 69 LSTM Alumni and Friends 26 FEATURE: Lung 70 Fundraising Health and TB 71 Estates 30 Department of International 72 People and Culture Public Health 73 Staff Overview 33 FEATURE: HIV 74 Structure, governance and 36 Partnerships management 40 FEATURE: Maternal, 76 Officers 2018/19 Newborn and Child Health 77 Awards and Honours 44 Public Engagement 78 Lectures and Seminars 46 FEATURE: Innovation, Discovery and Development 79 Publications 50 Health Goals Malawi 80 Consortia 52 FEATURE: Health Policy and 81 LSTM Pioneers Health Systems Research 82 Public Benefit Statement 56 Research Funders 83 Editorial Colophon Children from Nthumba village in Chikwawa district, Malawi, enjoy playing new games with their teacher.
    [Show full text]
  • Neurimminfl2018018622 1..3
    Volume 6, Number 2, March 2019 Neurology.org/NN A peer-reviewed clinical and translational neurology open access journal CLINICAL/SCIENTIFIC NOTE Balint syndrome in anti-NMDA receptor encephalitis e532 ARTICLE Real-world validation of the 2017 McDonald criteria for pediatric MS e528 ARTICLE HIV is associated with endothelial activation despite ART, in a sub-Saharan African sett ing e531 ARTICLE Mouse model of anti-NMDA receptor post–herpes simplex encephalitis e529 Academy Officers Neurology® is a registered trademark of the American Academy of Neurology (registration valid in the United States). Ralph L. Sacco, MD, MS, FAAN, President Neurology® Neuroimmunology & Neuroinflammation (eISSN 2332-7812) is an James C. Stevens, MD, FAAN, President Elect open access journal published online for the American Academy of Neurology, Ann H. Tilton, MD, FAAN, Vice President 201 Chicago Ave, Minneapolis, MN 55415, by Wolters Kluwer Health, Inc. at 14700 Citicorp Drive, Bldg 3, Hagerstown, MD 21742. Business offices are Carlayne E. Jackson, MD, FAAN, Secretary located at Two Commerce Square, 2001 Market St., Philadelphia, PA 19103. Production offices are located at 351 West Camden Street, Baltimore, MD Janis M. Miyasaki, MD, MEd, FRCPC, FAAN, Treasurer 21201-2436. © 2019 American Academy of Neurology. Terrence L. Cascino, MD, FAAN, Past President Neurology® Neuroimmunology & Neuroinflammation is an official journal of the American Academy of Neurology. Journal website: Neurology.org/NN, AAN website: AAN.com Executive Office, American Academy of Neurology Copyright and Permission Information: Please go to the journal website Catherine M. Rydell, CAE, Executive Director/CEO (www.neurology.org/nn) and click the Permissions tab for the relevant article.
    [Show full text]